{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:30:20Z","timestamp":1790487020839,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.neulet.2006.10.039","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T14:16:09Z","timestamp":1163686569000},"page":"98-103","source":"Crossref","is-referenced-by-count":192,"title":["Metformin therapy in a transgenic mouse model of Huntington's disease"],"prefix":"10.1016","volume":"411","author":[{"given":"Thong C.","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Buescher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Oatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Funk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raeann L.","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari R.","family":"Hoyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2006.10.039_bib1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/nbdi.2002.0562","article-title":"Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression","volume":"11","author":"Andreassen","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2006.10.039_bib2","first-page":"76","article-title":"The top 200 generic drugs in 2003\/The top 200 branded drugs in 2003","volume":"148","author":"Anonymous","year":"2003","journal-title":"Drug Topics"},{"key":"10.1016\/j.neulet.2006.10.039_bib3","first-page":"439","article-title":"Biguanide (Experimenteller Teil)","volume":"vol. 29","author":"Beckmann","year":"1971"},{"key":"10.1016\/j.neulet.2006.10.039_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","article-title":"The energetics of Huntington's disease","volume":"29","author":"Browne","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neulet.2006.10.039_bib5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2006.10.039_bib6","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1471-4159.2005.03036.x","article-title":"Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease","volume":"93","author":"Brustovetsky","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2006.10.039_bib7","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2006.10.039_bib8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1046\/j.1471-4159.2003.01706.x","article-title":"Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice","volume":"85","author":"Dedeoglu","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2006.10.039_bib9","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0006-2952(02)00858-4","article-title":"Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain function","volume":"63","author":"Detaille","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neulet.2006.10.039_bib10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.0.1380269","article-title":"Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome","volume":"138","author":"Diamanti-Kandarakis","year":"1998","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.neulet.2006.10.039_bib11","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","article-title":"Weight loss in early stage of Huntington's disease","volume":"59","author":"Djousse","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2006.10.039_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1074\/jbc.275.1.223","article-title":"Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I","volume":"275","author":"El-Mir","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2006.10.039_bib13","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","article-title":"Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease","volume":"20","author":"Ferrante","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2006.10.039_bib14","first-page":"159","article-title":"Metformin increases insulin-stimulated glucose transport in insulin-resistant human skeletal muscle","volume":"17","author":"Galuska","year":"1991","journal-title":"Diab. Metab."},{"key":"10.1016\/j.neulet.2006.10.039_bib15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.20754","article-title":"Low stability of Huntington muscle mitochondria against Ca2+ in R6\/2 mice","volume":"59","author":"Gizatullina","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2006.10.039_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2006.10.039_bib17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1042\/BJ20040885","article-title":"Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study","volume":"382","author":"Guigas","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.neulet.2006.10.039_bib18","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1210\/jc.2002-021394","article-title":"Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2","volume":"88","author":"Gunton","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neulet.2006.10.039_bib19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"issue":"Suppl.","key":"10.1016\/j.neulet.2006.10.039_bib20","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nn931","article-title":"From chemical to drug: neurodegeneration drug screening and the ethics of clinical trials","volume":"5","author":"Heemskerk","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neulet.2006.10.039_bib21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/WNL.57.3.397","article-title":"A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease","volume":"57","author":"HSG","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2006.10.039_bib22","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1210\/en.131.3.1165","article-title":"Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells","volume":"131","author":"Hundal","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.neulet.2006.10.039_bib23","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2337\/diabetes.49.12.2063","article-title":"Mechanism by which metformin reduces glucose production in type 2 diabetes","volume":"49","author":"Hundal","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.neulet.2006.10.039_bib24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00221-005-2357-z","article-title":"Atypical diabetes associated with inclusion formation in the R6\/2 mouse model of Huntington's disease is not improved by treatment with hypoglycaemic agents","volume":"166","author":"Hunt","year":"2005","journal-title":"Exp. Brain. Res."},{"key":"10.1016\/j.neulet.2006.10.039_bib25","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","article-title":"Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy","volume":"43","author":"Jenkins","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2006.10.039_bib26","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/WNL.50.5.1357","article-title":"1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers","volume":"50","author":"Jenkins","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2006.10.039_bib27","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/0026-0495(93)90284-U","article-title":"The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients","volume":"42","author":"Johnson","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.neulet.2006.10.039_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","author":"Kirpichnikov","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neulet.2006.10.039_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/exnr.2002.7864","article-title":"Phenformin suppresses calcium responses to glutamate and protects hippocampal neurons against excitotoxicity","volume":"175","author":"Lee","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2006.10.039_bib30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","article-title":"The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies","volume":"2","author":"Li","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neulet.2006.10.039_bib31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I","article-title":"Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy","volume":"48","author":"Lodi","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2006.10.039_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(01)00261-3","article-title":"Evaluation of R6\/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus","volume":"126","author":"Luesse","year":"2001","journal-title":"Behav. Brain. Res."},{"key":"10.1016\/j.neulet.2006.10.039_bib33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2006.10.039_bib34","doi-asserted-by":"crossref","unstructured":"M.J. Mihm, D.M. Amann, B.L. Schanbacher, J.A. Bauer, K.R. Hoyt, Cardiac dysfunction in the R6\/2 mouse model of Huntington's disease, Neurobiol. Dis., doi:10.1016\/j.nbd.2006.09.016, in press.","DOI":"10.1016\/j.nbd.2006.09.016"},{"issue":"Pt 3","key":"10.1016\/j.neulet.2006.10.039_bib35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/0264-6021:3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.neulet.2006.10.039_bib36","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neulet.2006.10.039_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1113\/jphysiol.2006.110122","article-title":"Developing a head for energy sensing: AMP-activated protein kinase as a multifunctional metabolic sensor in the brain","volume":"574","author":"Ramamurthy","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.neulet.2006.10.039_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3940(01)02326-6","article-title":"Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model","volume":"315","author":"Schilling","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2006.10.039_bib39","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0896-6273(95)90345-3","article-title":"Widespread expression of Huntington's disease gene (IT15) protein product","volume":"14","author":"Sharp","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2006.10.039_bib40","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2337\/diabetes.41.3.354","article-title":"Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM","volume":"41","author":"Widen","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.neulet.2006.10.039_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2006.10.039_bib42","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394006011517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394006011517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T06:54:13Z","timestamp":1555916053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394006011517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0304394006011517"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2006.10.039","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}